These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7693976)

  • 1. F0-containing noninfectious Sendai virus can initiate replication in mouse lungs but requires a relatively long incubation period.
    Kiyotani K; Sakaguchi T; Fujii Y; Yoshida T
    J Virol; 1993 Dec; 67(12):7618-22. PubMed ID: 7693976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumotropism of Sendai virus in relation to protease-mediated activation in mouse lungs.
    Tashiro M; Homma M
    Infect Immun; 1983 Feb; 39(2):879-88. PubMed ID: 6299951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Budding site of Sendai virus in polarized epithelial cells is one of the determinants for tropism and pathogenicity in mice.
    Tashiro M; Seto JT; Choosakul S; Yamakawa M; Klenk HD; Rott R
    Virology; 1992 Apr; 187(2):413-22. PubMed ID: 1312267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of proteolytic activation of Sendai virus in mouse lung.
    Tashiro M; Homma M
    Arch Virol; 1983; 77(2-4):127-37. PubMed ID: 6314932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of mice from wild-type Sendai virus infection by a trypsin-resistant mutant, TR-2.
    Tashiro M; Homma M
    J Virol; 1985 Jan; 53(1):228-34. PubMed ID: 2981341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of mice by a protease inhibitor, aprotinin, against lethal Sendai virus pneumonia.
    Hayashi T; Hotta H; Itoh M; Homma M
    J Gen Virol; 1991 Apr; 72 ( Pt 4)():979-82. PubMed ID: 1707950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumopathogenicity of a Sendai virus protease-activation mutant, TCs, which is sensitive to trypsin and chymotrypsin.
    Itoh M; Ming TD; Hayashi T; Mochizuki Y; Homma M
    J Virol; 1990 Nov; 64(11):5660-4. PubMed ID: 2170692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ tropism of Sendai virus in mice: proteolytic activation of the fusion glycoprotein in mouse organs and budding site at the bronchial epithelium.
    Tashiro M; Yamakawa M; Tobita K; Klenk HD; Rott R; Seto JT
    J Virol; 1990 Aug; 64(8):3627-34. PubMed ID: 2164589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate protection of mice from lethal wild-type Sendai virus (HVJ) infections by a temperature-sensitive mutant, HVJpi, possessing homologous interfering capacity.
    Kiyotani K; Takao S; Sakaguchi T; Yoshida T
    Virology; 1990 Jul; 177(1):65-74. PubMed ID: 2162116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity.
    Tashiro M; Yokogoshi Y; Tobita K; Seto JT; Rott R; Kido H
    J Virol; 1992 Dec; 66(12):7211-6. PubMed ID: 1331518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumotropic revertants derived from a pantropic mutant, F1-R, of Sendai virus.
    Tashiro M; James I; Karri S; Wahn K; Tobita K; Klenk HD; Rott R; Seto JT
    Virology; 1991 Sep; 184(1):227-34. PubMed ID: 1651590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumopathogenicity in mice of a Sendai virus mutant, TSrev-58, is accompanied by in vitro activation with trypsin.
    Mochizuki Y; Tashiro M; Homma M
    J Virol; 1988 Aug; 62(8):3040-2. PubMed ID: 2839720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease activation of Sendai virus infectivity; studies in non-permissive and permissive cells.
    Pennington TH
    J Gen Virol; 1978 Dec; 41(3):645-8. PubMed ID: 217954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody against the carboxyl terminus of the F2 subunit of Sendai virus fusion glycoprotein inhibits proteolytic activation.
    Tashiro M; Takeda M; Tanaka S; Nishimura N; Takenaka M; Kido H
    Virology; 1993 Jun; 194(2):882-5. PubMed ID: 8389088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypsin action on the growth of Sendai virus in tissue culture cells. IV. Evidence for activation of sendai virus by cleavage of a glycoprotein.
    Ohuchi M; Homma M
    J Virol; 1976 Jun; 18(3):1147-50. PubMed ID: 178921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of trypsin treatment to remove Sendai virus adhering to the zona pellucida of mouse preimplantation embryos.
    Lavilla-Apelo C; Kida H; Kanagawa H
    Jpn J Vet Res; 1991 Dec; 39(2-4):133-41. PubMed ID: 1668245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in specific cleavability of the Sendai virus fusion protein: implications for pathogenicity in mice.
    Tashiro M; Seto JT; Choosakul S; Hegemann H; Klenk HD; Rott R
    J Gen Virol; 1992 Jun; 73 ( Pt 6)():1575-9. PubMed ID: 1339465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Sendai virus infectivity by an enzyme in chicken amniotic fluid.
    Appleyard G; Davis GB
    J Gen Virol; 1983 Apr; 64 (Pt 4)():813-23. PubMed ID: 6300304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Component(s) of Sendai virus that can induce interferon in mouse spleen cells.
    Ito Y; Hosaka Y
    Infect Immun; 1983 Mar; 39(3):1019-23. PubMed ID: 6301988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residues in the heptad repeat a region of the fusion protein modulate the virulence of Sendai virus in mice.
    Luque LE; Bridges OA; Mason JN; Boyd KL; Portner A; Russell CJ
    J Virol; 2010 Jan; 84(2):810-21. PubMed ID: 19906935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.